Ali-Jackson Kamil

Rigel Pharmaceuticals, Inc. · Director

Ali-Jackson Kamil is listed in public filings as director. This Ali-Jackson Kamil insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Rigel Pharmaceuticals, Inc. (RIGL), and PDS Biotechnology Corporation (PDSB). Investors use Ali-Jackson Kamil's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Rigel Pharmaceuticals, Inc.RIGL$73k2.5k sharesSellMay 26, 2026$29.17--